West Virginia University Logo

February 26, 2015


SAMHSA Prescription Drug Abuse Weekly Update
Issue 111  |  February 26, 2015
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional Education National News International News Northeast/MidAtlantic News South News Midwest News West News Other Resources Upcoming Webinars Grant Announcements Take-Back Events and Drop Boxes Upcoming Conferences and Workshops


Dinah Kanate, David Folk, Sharon Cirone, Janet Gordon, Mike Kirlew, Terri Veale, Natalie Bocking, Sara Rea, and Len Kelly. 2015. "Communitywide Measures of Wellness in a Remote First Nations Community Experiencing Opioid Dependence: Evaluating Outpatient Buprenorphine–Naloxone Substitution Therapy in the Context of a First Nations Healing Program." Canadian Family Physician 61(2):160–65.

A remote First Nations community in northwestern Ontario developed opioid-dependence treatment that combines First Nations healing strategies and substitution therapy with buprenorphine–naloxone. They treated 140 self-referred persons, or 41 percent of adults in the community. One year after the program began, police criminal charges had fallen by 61 percent, child protection cases had fallen by 58 percent, school attendance had increased by 33 percent, and seasonal influenza immunizations had risen by 350 percent. Attendance at community events is now robust, and sales at the local general store have gone up almost 20 percent.

Read more:

Roger Chou, Judith A. Turner, Emily B. Devine, Ryan N. Hansen, Sean D. Sullivan, Ian Blazina, Tracy Dana, Christina Bougatsos, and Richard A. Deyo. 2015. "The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop." Annals of Internal Medicine 162(4):276–86. DOI:10.7326/M14–2559.

Researchers evaluated evidence on the efficacy and harms of long-term (>3 months) opioid therapy for chronic pain in adults. No study of opioid therapy versus no-opioid therapy has evaluated long-term (>1 year) outcomes related to pain, function, quality of life, opioid abuse, or addiction. Good- and fair-quality observational studies suggest that opioid therapy for chronic pain is associated with increased risk for overdose, opioid abuse, fractures, myocardial infarction, and markers of sexual dysfunction. Although few studies analyze most of these outcomes, for some harms higher doses are associated with increased risk. Evidence on effectiveness and harms of different opioid dosing and risk mitigation strategies is limited.

Read more:

Journal Articles and Reports

Matthew Miller, Catherine W. Barber, Sarah Leatherman, Jennifer Fonda, John A. Hermos, Kelly Cho, and David R. Gagnon. 2015. "Prescription Opioid Duration of Action and the Risk of Unintentional Overdose Among Patients Receiving Opioid Therapy." JAMA Internal Medicine, DOI:10.1001/jamainternmed.2014.8071.

Analysis of Veterans Administration Healthcare System data on patients with chronic painful conditions who began therapy with opioid analgesics between 2000 and 2009 identified 319 unintentional overdose events. After adjustment for age, sex, opioid dose, and other clinical characteristics, patients receiving long-acting opioids were 2.33 times as likely to overdose compared with patients receiving short-acting opioids. The risk associated with long-acting agents was particularly marked during the first 2 weeks after initiation of treatment (Hazard Ratio=5.25).

Read more:

Christopher P. Salas–Wright, Michael G. Vaughn, Jenny Ugalde, and Jelena Todic. 2015. "Substance Use and Teen Pregnancy in the United States: Evidence From the National Survey on Drug Use and Health 2002–12." Addictive Behaviors. DOI:10.1016/j.addbeh.2015.01.039.

This article adds to the evidence that pregnant girls ages 12 to 17 tend to be multiproblem youths. Employing 2002–12 data from the National Survey on Drug Use and Health, it finds that pregnant teens were significantly more likely to have experimented with a variety of substances and to have met criteria for alcohol and illicit drug use disorders. The correlations were especially strong for pregnant girls ages 12 to 14.

Read more:

Jon Streltzer, Raymond Davidson, and Deborah Goebert. 2015. "An Observational Study of Buprenorphine Treatment of the Prescription Opioid–Dependent Pain Patient." American Journal on Addictions. DOI: 10.1111/ajad.12198.

Forty-three consecutive outpatient psychiatric clinic chronic pain patients with a DSM–IV diagnosis of opioid dependence who were treated with buprenorphine during a 3-year period were monitored for follow-up periods of up to 5 years. Treatment with buprenorphine was effective. Most patients had less pain after treatment of the opioid dependence. A history of substance abuse did not correlate with effectiveness.

Read more:

Barbara J. Turner and Yuanyuan Liang. 2015. "Drug Overdose in a Retrospective Cohort With Noncancer Pain Treated With Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions With Mental Health Disorders." Journal of General Internal Medicine. DOI: 10.1007/s11606–015–3199–4.

This study analyzed claims data from a nationwide health maintenance organization on beneficiaries ages 18 to 64, enrolled for at least 1 year between January 2009 and July 2012, who filled at least two prescriptions for schedule 2 or 3 opioids for noncancer pain. A total of 1,385 enrollees (0.67 percent) experienced a drug overdose (incidence rate 421/100,000 person-years). Odds of overdose rose monotonically with daily opioid dose. It was highest (OR=7.1) for persons with depression and a high opioid dose (≥100 mg). Longer-term antidepressant use (91 to 180 days) was protective for persons with depression, with 20 percent lower odds of overdose versus short term (1 to 30 days) or none. Odds of overdose increased with the duration of benzodiazepine therapy among all subjects, with more than 2.5-fold odds for 91 to 180 days versus none.

Read more:

Lyncean Ung, Ronald Dvorkin, Steven Sattler, and David Yens. 2015. "Descriptive Study of Prescriptions for Opioids From a Suburban Academic Emergency Department Before New York's I–STOP Act." Western Journal of Emergency Medicine 16(1):62–66. DOI:10.5811/westjem.2014.12.22669.

A retrospective medical record review of prescriptions written for patients 21 and older who presented at a suburban New York academic emergency department (ED) between July 2011, and June 2012 identified 9,502 prescriptions for opioids out of 63,143 prescriptions written for 69,500 adult patients. Only 26 of the opioid prescriptions provided more than a 5-day supply. Thus the I–STOP law, which requires New York prescribers to consult the prescription drug monitoring program before prescribing schedule 2, 3, and 4 controlled substances for more than 5 days will not affect this academic ED.

Read more:

Brook E. Wells, Brian C. Kelly, H. Jonathon Rendina, and Jeffrey T. Parsons. 2015. "Prescription Drug Misuse and Sexual Behavior Among Young Adults." Journal of Sex Research. DOI:10.1080/00224499.2014.918085.

A random sample of attendees at electronic dance music venues, gay clubs, lesbian parties and clubs, indie rock venues, and the Brooklyn warehouse scene, identified 402 persons ages 18 to 29 who misused prescription drugs. Among the 76 percent of respondents who had sex in the past 90 days, 78 percent had sex without a condom and 47 percent had sex under the influence of prescription drugs. Being under the influence of prescription drugs did not affect the odds of condom use. Zero-inflated Poisson regression models indicated that white race, younger age, higher parental class, and being a heterosexual man were all associated with both sexual risk behavior and sex under the influence of prescription drugs. (Editor's note: The sample number is unknown.)

Read more:

Zhuo Yang, Barth L. Wilsey, Michele Bohm, Meghan Soulsby, Kakoli Roy, Dominique Ritley, Christopher Jones, and Joy Melnikow. 2015. "Defining Risk for Prescription Opioid Overdose: Pharmacy Shopping and Overlapping Prescriptions Among Long-Term Opioid Users in Medicaid." Journal of Pain. DOI:10.1016/j.jpain.2015.01.475.

Using claims data, researchers identified a multistate cohort of 90,010 Medicaid enrollees who used ≥3 opioid prescriptions for ≥90 days during 2008–10. Data analysis suggested defining pharmacy shopping as filling opioid prescriptions at four or more pharmacies in a 90-day interval. The overdose rate per 1,000 person years was 18.5 among patients with overlapping opioid prescriptions, 10.7 among pharmacy shoppers without overlapping prescriptions, 26.3 among patients with both behaviors, and 4.3 among those with neither condition. Adjusted hazard ratios for overdose were 3.0 for overlapping opioid prescriptions and 1.8 for pharmacy shopping.

Read more:

Professional Education

Ingrid A Binswanger and Jason M Glanz. 2015. "Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice." Substance Abuse. DOI:10.1080/08897077.2014.991058.

Pharmaceutical opioid deaths among youth have increased in the last decade. Parents may intentionally share opioids with youths, because of low perceived risks or limited knowledge, and youths may divert opioids from parents' medicine cabinets. Safe medication storage has long been mandated by treatment programs that provide pharmacologically supported treatment of opioid use disorders, but it is not generally encouraged or required for pharmaceutical opioids prescribed for pain. Greater attention is needed on the development, evaluation, and implementation of three preventive strategies: 1) fully informing adults prescribed opioids about the risks of opioids to family members, 2) providing locked medication safe-storage devices, and 3) educating parents on safe disposal options. However, a critical evidence base is lacking for these opioid safety interventions.

Read more:

Kyle Simon, Stacey L. Worthy, Michael C. Barnes, and Benjamin Tarbell. 2015. "Abuse-Deterrent Formulations: Transitioning the Pharmaceutical Market to Improve Public Health and Safety." Therapeutic Advances in Drug Safety. DOI: 10.1177/2042098615569726.

This article weighs the evidence of abuse-deterrent formulations as a method to reduce prescription drug abuse while ensuring access to vital medications for individuals with legitimate need. Although abuse-deterrent technology is relatively new, it has reduced prescription drug abuse and its consequences. Federal abuse-deterrent formulation policy does not reflect the urgency of the prescription drug abuse epidemic and does not go far enough toward changing the status quo. Policies must be implemented to encourage innovation and a market shift toward abuse-deterrent formulations by ensuring that any generic medication referencing a branded abuse-deterrent formulation demonstrates that it does not have abuse-deterrent properties inferior to the branded abuse-deterrent formulation product. Policies also should require federal prescription drug benefit plans to cover abuse-deterrent formulations.

Read more:

National News

Lynch, Rogers Launch Congressional Caucus on Prescription Drug Abuse
Floyd County (Ky.) Times
February 17, 2015

U.S. Rep. Stephen F. Lynch (Mass.) and U.S. Rep. Hal Rogers (Ky.) announced the relaunch of the bipartisan Congressional Caucus on Prescription Drug Abuse. The caucus seeks to raise awareness of abuse and to work toward innovative and effective policy solutions that incorporate treatment, prevention, education, law enforcement, and research.

Read more:

Surescripts Leverages Technology to Help Doctors Address Prescription Fraud and Abuse
February 19, 2015

Surescripts, the nation's largest health information network, is working to improve care and curb prescription fraud, diversion, and abuse by encouraging pharmacists and doctors to adopt the electronic prescribing of controlled substances. In 2015, Surescripts expects to deliver at least 5 million electronic prescriptions of controlled substances, representing a nearly 400 percent increase over the prior year. Currently, electronic prescribing of controlled substances is legal in 48 states and the District of Columbia. More than 70 percent of pharmacies are ready to receive electronic prescriptions for controlled substances, but only 6 percent of prescribers are ready to send them.

Read more:

U.S. Review for Pfizer's Abuse-Resistant Painkiller
Selina McKee, Pharmacy Times
February 15, 2015

Pfizer has applied for FDA approval for ALO–02, an abuse-resistant extended-release oxycodone formulation with a sequestered core of naltrexone to discourage crushing.

Read more:

Collegium Pharmaceutical Secures Food and Drug Administration Acceptance for Filing of NDA for XTAMPZA ER(TM) (Oxycodone Extended-Release Capsules), an Abuse-Deterrent Analgesic for Chronic Pain
Globe Newswire
February 17, 2015

Collegium Pharmaceutical, Inc., applied for U.S. Food and Drug Administration approval for XTAMPZA ER, an abuse-deterrent, extended-release oxycodone formulation. The drug is designed to maintain its extended-release profile even after tampering.

Read more:

Toomey Calls for Action in Prescription Drug Monitoring Program Reauthorization
Alysa Poindexter, Fox 43
February 19, 2015

U.S. Sen. Pat Toomey (Pa.) called for Senate action to support the reauthorization of the National All Schedules Prescription Electronic Reporting program. The program would help states develop a prescription drug monitoring program that gives healthcare providers and law enforcement access to a patient's prescription drug history. (Includes video: 43 seconds.)

Read more:

Benzodiazepines: Helpful or Harmful?
Kirstin Fawcett, U.S. News and World Report
February 19, 2015

This article discusses types of benzodiazepines and their side effects. Although benzodiazepines can be safe for short-term use, people with a history of alcoholism or drug addiction should not take them.

Read more:

International News

Queensland Doctor Shoppers Pop Their Prescription Pills on Black Market
Damon Guppy, Courier Mail
February 16, 2015

Queensland (in Australia) is seeing a surge in overdoses because a doctor-shopping drug dealer is selling opioids on the black market. A 20-tablet box of oxycodone (100mg) can be purchased legally under the Pharmaceutical Benefits Scheme for about $37. A single pill can be sold illegally for about $100. Statewide hospital data showed that opioids were responsible for about 4,100 of the 16,000 overdoses in the past 3 years. The drug-induced death rate was 4.9 persons per 100,000 in 2012.

Read more:

Nova Scotia Unveils New Drug Education Program for Junior High Students
CTV Atlantic
February 20, 2015

Nova Scotia Health and Wellness Minister Leo Glavine unveiled a new drug education program for students in grades 7 to 9, the first of its kind in Canada. Lesson plans are aimed at getting students to talk openly about the pressures and influences that may lead to alcohol, cannabis, and prescription drug use. The curriculum will be used for the remainder of the school year. (Includes video: 1 minute 54 seconds.)

Read more:

Benzodiazepines Leading Cause of Drug Deaths on Cape Breton Island, Nova Scotia
CBC News
February 16, 2015

Prescription benzodiazepines are the leading cause of drug deaths on Cape Breton Island, Nova Scotia, and the second-leading cause of drug-related deaths in Halifax, Nova Scotia. Last year, 12 persons died of overdoses in Cape Breton County and 25 died of overdoses in Halifax. Hydromorphone or Dilaudid and Valium caused the most overdoses. The Nova Scotia government is moving to join other provinces in tracking benzodiazepines.

Read more:

Northeast/MidAtlantic News

Gov. Baker Unveils Plan to Fight Prescription Drug Abuse
Boston Herald
February 19, 2015

Massachusetts health officials reported that 978 people died of unintentional opioid overdoses in 2013, an increase of 46 percent over 2012. Gov. Charlie Baker announced formation of a 16-member task force assigned to formulate a statewide strategy for dealing with heroin and prescription drug addiction, treatment, and recovery. The group will hold several public meetings and submit recommendations in May.

Read more:

Massachusetts Medical Society Forms Task Force on Opioid Abuse
February 19, 2015

The Massachusetts Medical Society announced formation of an opioid task force. It will examine ways to address prescription drug abuse and to improve communications among prescribers.

Read more:

Painkiller Addiction Crisis: Pennsylvania Prescription Drug Database Faces Lack of Money
David Wenner, Pennsylvania Media Group
February 19, 2015

Pennsylvania expected to launch its prescription drug database by June 30, until it learned there is no money in the state budget for the project. One third of the funding will come from the attorney general's office budget, but the source of the remainder is unclear.

Read more:

Anti-Addiction Nonprofit Unveils Multistate Public Advocacy Campaign
Market Wired
February 19, 2015

Shatterproof, a Connecticut nonprofit organization whose mission is to protect children from addiction, is investing more than $500,000 this year in advocacy efforts aimed at combating drug overdose deaths.

Read more:

Antiheroin Ads Coming to Billboards, Train Stations
Matt Coyne, Journal News
February 17, 2015

The next phase of New York's Combat Heroin campaign includes a month-long media blitz on billboards and train stations across the Hudson Valley. It also includes online advertisements, social media posts, and commercials. The campaign educates the public about the heroin epidemic and raises awareness about alcohol and prescription drug abuse as gateways to heroin use.

Read more:

Sen. Hannon Introduces Bill to Allow Easier Safe Disposal of Controlled Substances
Long Island Exchange
February 17, 2015

New York state Sen. Kemp Hannon has introduced legislation to permit retail pharmacies to collect unused controlled substances in New York on a voluntary basis. The state's Department of Health would oversee the program and ensure that collectors comply with federal and state laws.

Read more:

Pennsylvania Bill Would Hike Penalty for Drug Thefts From Seniors
Myles Snyder, ABC 27
February 19, 2015

A Pennsylvania state representative introduced House Bill 511, which would increase jail time for individuals stealing medicine from the elderly. The minimum sentence would be 1 year for stealing prescription drugs from someone over age 60, but 6 months if the theft is by deception.

Read more:

Lebanon County, Pa., Coroner: Drug Deaths Up, Suicides Down
John Latimer, Lebanon Daily News
February 19, 2015

The number of suicides in Lebanon County, Pa., dropped by 20 percent in 2014, but drug-related deaths more than doubled.

Read more:

Hagerstown, Md., Police Officer Becomes Department's First Drug Recognition Expert
Kristin Garriss, Your4State.com
February 13, 2015

A Hagerstown, Md., police officer became the department's first Drug Recognition Expert (DRE). The DRE performs a 12-step standardized test on impaired drivers that includes a series of medical questions and physical examinations. (Includes video: 1 minute 13 seconds.)

Read more:

Calvert County, Md., Sheriff's Office Brings Awareness to Ongoing Heroin Overdoses and Narcan
Southern Maryland News Net
February 14, 2015

The Calvert County, Md., Sheriff's Office has trained and equipped patrol deputies with Narcan to address the county's rise in heroin overdoses.

Read more:

South News

Sarasota, Fla., Representatives Sponsor Bills to Cut Down on Opioid Overdoses
Kate Irby, Bradenton (Fla.) Herald
February 18, 2015

Florida state Rep. Julio Gonzalez filed legislation that would allow doctors in the state to prescribe naloxone to patients at risk of overdosing or caregivers who have contact with at-risk patients. Another bill would allow all emergency responders to possess and administer naloxone.

Read more:

Dare County Has One of Highest Overdose Rates in North Carolina
Jeff Hampton, Virginia Pilot
February 16, 2015

Dare County has one of highest rates of prescription drug overdose in North Carolina. From 2010 through 2012, more than 100,000 opioid prescriptions were filled in Dare County, among the highest rates in the state.

Read more:

Midwest News

Report: Teens Increasingly Abusing Prescription Drugs
Jessica Smith, WISHTV
February 17, 2015

The number of Indiana teens who have abused prescription drugs nearly doubled from 2013 to 2014, rising to 13.5 percent. (Includes video: 1 minute 57 seconds.)

Read more:

Minnesota Product Changes How Police Combat Prescription Drug Abuse
Josh Rosenthal, WDAZ
February 17, 2015

Some Minnesota police departments are using the Deterra Drug Deactivation System to help curb prescription drug abuse. The Deterra pouch contains a proprietary carbon that deactivates the prescription drugs when mixed with water. The pouch can then be thrown into the garbage.

Read more:

Officials Prescribe Caution for Medication Thefts
Caitlin Turner, Chillicothe (Ohio) Gazette
February 17, 2015

The Chillicothe, Ohio, Police Department warned residents that prescription medication thefts are becoming an almost daily occurrence. The best way individuals can protect prescription drugs is to limit access to them. Keep them in lock boxes, a cabinet, or anywhere else people cannot see them.

Read more:

Nurses Lobby for Medicaid Expansion, Drug Monitoring
Landon Reeves, News Tribune
February 19, 2015

The Missouri Nurses Association held its annual nurse advocacy day at the state capitol. More than 600 nurses and nursing students pushed for prescription drug monitoring, opposed repeal of prescriptive authority to advance-care nurses, and urged Medicaid expansion.

Read more:

Lawmakers Push Drug-Overdose Medication
Megan Kennedy, Civitas Media Group
February 16, 2015

Ohio representatives introduced House Bill 4, which would expand access to naloxone.

Read more:

Heroin Deaths Surpass Traffic Fatalities in Milwaukee County, Wisc.
Nick Bohr, WISN
February 18, 2015

More people are dying from heroin in Milwaukee County, Wisc., than from car crashes. In 2014, 119 Milwaukeeans died from heroin, up from 69 in 2013. (Includes video: 2 minutes 18 seconds.)

Read more:

West News

Addicted at Birth: Number of Babies Born to Mothers Using Heroin, Methamphetamine, and Prescriptions Grows
Aspen Stoddard and Melissa Anderson, KCSG
February 16, 2015

In Washington County, Utah, Dixie Regional Medical Center alone sees a dozen babies born each year who have been exposed to drugs while in utero. From 2009 through 2012, 1,476 Utah mothers used illicit drugs during pregnancy; 29.5 percent of their babies tested positive for illicit drugs at birth. (Includes video: 3 minutes 11 seconds.)

Read more:

Overdose Antidote Access Bill Moves to House Floor
Nathan Brown, Times News
February 19, 2015

Idaho's House Health and Welfare Committee approved a bill that would allow anyone to get a prescription for naloxone and would protect Good Samaritans who administer the drugs. The bill now heads to the House of Representatives.

Read more:

Utah Bill Would Prevent Law Enforcement From Abusing Substance Abuse Database
Jennie Christensen, Cache Valley Daily
February 16, 2015

Utah state Sen. Todd Weiler sponsored a bill that would require law enforcement to go to court and show probable cause, to use the Utah prescription drug monitoring program database.

Read more:

Other Resources

Global Advisory Committee Strategic Solutions Working Group Prescription Drug Monitoring Programs Task Team. 2015. "Call to Action and Issue Brief: Justice System Use of Prescription Drug Monitoring Programs—Addressing the Nation's Prescription Drug and Opioid Abuse Epidemic." Washington, D.C.: Global's Library of Resources, Global Information Sharing Toolkit, January.

This resource offers justice practitioners and policymakers a prescription drug monitoring program best-practices checklist, a compendium of resources and references, and next steps to help them address this critical public safety and public health challenge.

Read more:

Upcoming Webinars

Lessons Learned From Implementing Project Lazarus in North Carolina—A Clinical and Community-Based Intervention to Prevent Prescription Drug Overdose
Society for Advancement of Violence and Injury Research
Part 1: March 18, 2015 | 2:00 p.m. (ET)
Part 2: April 1, 2015 | 2:00 p.m. (ET)

Part 1 of this free Webinar will concentrate on lessons learned by key North Carolina stakeholders implementing the core components of the Project Lazarus model, a clinical and community-based prescription drug overdose prevention program that promotes evidence-based and innovative interventions.

Part 2 will examine an array of evidence-based and evidence-building programs that community coalitions can choose to implement in their communities that reflect a medical and law enforcement–based, top-down, public health approach.

Part 1 Registration:

Part 2 Registration:

Grant Announcements

Strategic Prevention Framework Partnerships for Success State and Tribal Initiative
Substance Abuse and Mental Health Services Administration

Deadline: March 16, 2015

Drug-Free Communities Support Program
Substance Abuse and Mental Health Services Administration
Deadline: March 18, 2015

Drug-Free Communities Mentoring Program
Substance Abuse and Mental Health Services Administration
Deadline: April 14, 2015

Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders
National Institutes of Health
Deadline: April 15, 2015

Take-Back Events and Drop Boxes

State to Take Over Prescription Drug Take-Back Program
Bill Novak, Madison.com (Wisc.)
February 19, 2015

Prescription Drug Drop-Box Rated a Success in Quincy, Ill.
February 17, 2015

Red Barrel Project Now Has Harrisville, Mich., Location
Paige Trisko, Alpena (Mich.) News
February 19, 2015

Prescription Drug Disposal Available
Papillion (Neb.) Times
February 18, 2015

Romeoville Introduces Prescription Drug Collection Program
Shannon Antinori, Patch (Illinois)
February 18, 2015

Police Seek Drug Disposal Methods After Drug Enforcement Administration Program Ends
Emily Priddy, Southeast Missourian
February 16, 2015

Year-Round Drop Box Available at Allendale Police Headquarters
Karen Kleimann, Town Journal (New Jersey)
February 18, 2015

Somerset County Sheriff Provenzano Announces Medicine Drop Events
Messenger–Gazette (New Jersey)
February 19, 2015

Drug Disposal Now Available in Kimball, Neb.
Jeremy Downing, CBS 5
February 13, 2015

Police Work to Keep Prescription Pills Out of the Hands of Youth With Drop Box
Christine Karsten, WNDU (Indiana)
February 16, 2015

Buckland, Mass., Police Department Offers Safe Way to Dispose Old Medication
Alessandra Martinez, WWLP (Massachusetts)
February 13, 2015

Drug Take-Back Box Installed in York City, Pa., Police Station
Sean Philip Cotter, York Dispatch
February 20, 2015

Upcoming Conferences and Workshops

Collaborative Perspectives on Addiction 2015: "Changing Landscapes of Addiction"
Society of Addiction Psychology
March 6–7, 2015
Baltimore, Maryland

Pharmacy Diversion Awareness Conferences
Drug Enforcement Administration, Office of Diversion Control
March 28–29, 2015—Birmingham, Alabama
May 30–31, 2015—Norfolk, Virginia
June 27–28, 2015—Oklahoma City, Oklahoma

2015 AATOD Conference—Address a Public Health Crisis: Opioid Dependence
American Association for Treatment of Opioid Dependence, Inc. (AATOD)
March 28 through April 1, 2015
Atlanta, Georgia

National Prescription Drug Abuse Summit
April 6–9, 2015
Atlanta, Georgia

Forty-Eighth Annual Communicating Nursing Research Conference—Equity and Access: Nursing Research, Practice, and Education
Western Institute of Nursing
April 22–25, 2015
Albuquerque, New Mexico

Fourth Annual Generation Prescription Drug University Conference for Collegiate Prevention and Recovery
The Ohio State University College of Pharmacy
August 4–6, 2015
Columbus, Ohio

University of Michigan Injury Center Prescription Drug Overdose Summit
University of Michigan Injury Center
November 9, 2015
Ann Arbor, Michigan
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.